Assignee
HO MEI-LING
TW·5 granted patents·3 pending applications·18 citations·filing 2006–2012
Top patents by PatentIndex Score
8 records- 0190US8865220B2Method for controlled release of parathyroid hormone from encapsulated poly(lactic-glycolic)acid microspheresHO MEI-LING·Filed 2010·Granted Oct 21, 2014·16 cites·8 claims
- 0278US8470522B2Three-dimensional culture containing human articular chondrocytes with induced terminal differentiation changes and preparation process and uses of the sameHO MEI-LING·Filed 2006·Granted Jun 25, 2013·1 cites·21 claims
- 0370US8586533B2Treatment of early-stage osteoarthritisHO MEI-LING·Filed 2009·Granted Nov 19, 2013·0 cites·19 claims
- 0470US8530420B2Treatment of arthritis with parathyroid hormoneHO MEI-LING·Filed 2008·Granted Sep 10, 2013·1 cites·19 claims
- 0542US8883862B2Method for controlled release of parathyroid hormone from cross-linked hyaluronic acid hydrogelHO MEI-LING·Filed 2012·Granted Nov 11, 2014·0 cites·11 claims
- 0636US2013171197A1Hyaluronic acid hydrogel and use thereofHO MEI-LING·Filed 2011·Application pending·0 cites
- 0735US2012202064A1Poly(lactic-glycolic)acid cross linked alendronate (plga-aln) a short term controlled release system for stem cell differentiation and drug deliveryHO MEI-LING·Filed 2012·Application pending·0 cites
- 0832US2012045831A1Poly(lactic-glycolic)acid cross linked alendronate (plga-aln) a short term controlled release system for stem cell differentiation and drug deliveryHO MEI-LING·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →